New insights into the role of ID proteins in breast cancer metastasis: a MET affair
The establishment of lethal metastases depends on the capacity of a small number of cancer cells to regenerate a tumor after entering a target organ. Stankic and colleagues have identified a role for the inhibitor of differentiation protein, ID1, as a critical regulator of breast cancer stem-like properties and metastatic colonization. Under the control of tumor growth factor-beta signaling, ID1 induces mesenchymal-epithelial transition at the metastatic site by antagonizing the activity of the basic helix-loop-helix transcription factor Twist1. This study sheds light on mechanisms that initiate metastatic outgrowth, and strengthens the concept that epithelial-mesenchymal plasticity is crucial at different stages of metastasis.
|ISBN||1465-542X (Electronic) 1465-5411 (Linking)|
|Authors||Teo, W. S.; Nair, R.; Swarbrick, A.|
|Responsible Garvan Author||Prof Alexander Swarbrick|
|Publisher Name||BREAST CANCER RESEARCH|
|URL link to publisher's version||http://www.ncbi.nlm.nih.gov/pubmed/25927844|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/14123|